Device & safety

Device & safety information

Regulatory status, intended use and safety information for the SmartHeart® 12-lead ECG device.

Last updated

Warning. The use of SmartHeart® does not substitute for a medical emergency service. If you think a patient is experiencing a medical emergency or crisis, contact your local emergency services immediately.

Caution. Read the User Guide carefully and entirely before using SmartHeart®. A thorough understanding of its operation is required for correct and accurate ECG transmission. Federal law restricts this device to sale by or on the order of a physician. An ECG should always be forwarded for review by a qualified physician.

FDA clearance

510(k) numberK113514 (510(k) summary, PDF)
ClearedFebruary 22, 2012
ManufacturerSHL Telemedicine International Ltd.
ClassificationTelephone electrocardiograph transmitter and receiver, Class II, product code DXH, 21 CFR 870.2920
UsePrescription use (21 CFR 801 Subpart D)
Standards citedIEC 60601-2-51:2005; IEC 60601-2-25 (1993) +A1:1999

Indications for use

“The Smartheart device is intended to condition an electrocardiographic signal so that it can be transmitted digitally via Bluetooth technology and cell-phone or communication device to a remote location. The Smartheart device is designed to be used by a patient to transmit a 12 lead ECG and rhythm strip in real-time to enable review at a physician’s office, hospital or other medical receiving center.”
FDA 510(k) K113514, Indications for Use Statement

What SmartHeart® is, and is not

  • It records and transmits a resting 12-lead ECG with a rhythm strip.
  • It is not a continuous or intra-operative monitor.
  • The preliminary review supports, and does not replace, the clinician’s judgment. Cardiologist interpretation is a separate, on-request service.
  • It does not substitute for emergency services.

Power

Runs on AAA lithium batteries, with the capability to produce about 100 ECGs before the batteries need changing.